<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03701867</url>
  </required_header>
  <id_info>
    <org_study_id>BL39</org_study_id>
    <nct_id>NCT03701867</nct_id>
  </id_info>
  <brief_title>Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women</brief_title>
  <official_title>A Pilot Study to Explore Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will explore differences in energy metabolism and metabolic flexibility under
      various conditions in older men and women.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 14, 2018</start_date>
  <completion_date type="Actual">July 22, 2019</completion_date>
  <primary_completion_date type="Actual">July 22, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory Quotient</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Ratio of macronutrient oxidation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Biochemistries - Glucose</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Venous blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Biochemistries - Insulin</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Venous blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Biochemistries - Amino Acids</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Venous blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Biochemistries - Fatty Acids</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Venous blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Oxygenation</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Near Infrared Spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Fatigue</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Electromyography</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Energy Metabolism</condition>
  <arm_group>
    <arm_group_label>Metabolic Flexibility Tests Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Metabolic Flexibility Tests</intervention_name>
    <description>Energy Metabolism, Oxygenation, Body Composition, Blood Samples</description>
    <arm_group_label>Metabolic Flexibility Tests Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index (BMI) &gt;20.0 and &lt;39.0 kg/m2

          -  Ambulatory (may use assistance device e.g., cane, walker)

          -  Not a current smoker (within past 10 years)

          -  Low or moderate risk based on the responses from the AHA/ACSM Health/Fitness Facility
             Preparticipation Screening Questionnaire

          -  Normal muscle mass and strength/performance or sarcopenia included in low muscle mass
             and low grip strength

          -  If on thyroid medication or hormone replacement therapy, has been on a constant dosage
             for at least 2 months prior to Screening Visit

          -  Willingness to follow protocol as described

          -  Voluntarily signed and dated an informed consent form (ICF), approved by an
             Independent Ethics Committee (IEC)/Institutional Review Board (IRB) prior to any
             participation in the study

        Exclusion Criteria:

          -  Active/treated disease, under the care of a physician, for the following:
             metabolic/endocrine (diabetes), hepatic, or renal disease, myocardial infarction,
             peripheral vascular disease, respiratory or neuromuscular disease

          -  Participates in a resistance exercise program

          -  Poor appetite with recent unexplained weight loss over the past 6 months

          -  Current infection (requiring medication or which might be expected to require
             hospitalization); has had inpatient surgery, or corticosteroid treatment (excluding
             topical creams) in the last 3 months or antibiotics in the last 3 weeks.

          -  Active malignancy, excluding carcinoma in-situ of the cervix, cutaneous malignancies
             (basal cell carcinoma, squamous cell carcinoma, except melanoma)

          -  Chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis A, B
             or C, or HIV

          -  Taking medications/dietary supplements or substances that could profoundly modulate
             metabolism in the opinion of the principal investigator or study physician, Exceptions
             for multi-vitamin/mineral supplement, topical or optical steroids and short-term use
             (less than two weeks) of dexamethasone

          -  Allergy or intolerance to any foods

          -  History of gastrointestinal disease, or surgeries, gastroparesis, or taking
             medications that are known in the opinion of the PI or study physician to interfere
             with consumption/digestion/absorption of nutrients

          -  Eating disorder, severe dementia or delirium, history of significant neurological or
             psychiatric disorder, alcoholism, substance abuse or other conditions that may
             interfere with compliance with study protocol procedures in the opinion of the
             principal investigator or study physician

          -  Participant in a concomitant AN trial or trial of a non-registered drug (or is within
             the 30 day follow-up period for such a trial) or that otherwise conflicts with this
             study unless otherwise approved
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vikkie Mustad, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nebraska</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>October 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2018</study_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

